LMW Earnings Call Transcript: Key Takeaways
LMW's Q1 FY27 results show flat revenue vs. Q4 FY26 despite 24% YoY growth, masking underlying margin pressure in machine tools.
ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first.
Time
2,764 announcements with these filters
LMW's Q1 FY27 results show flat revenue vs. Q4 FY26 despite 24% YoY growth, masking underlying margin pressure in machine tools.
Coforge Q1 FY27 results show 49% YoY revenue growth (INR) and 110% YoY PAT increase, significantly boosted by the Encora acquisition. Management highlights strong AI-led demand and record order book visibility.
Digitide returned to profitability in Q1 FY27 with revenue of ₹775 Cr, up 5.3% YoY. Strategy focuses on an AI-first operating model and international expansion.
Epigral reported 15% revenue growth and 25% EBITDA margins despite Red Sea logistical disruptions. Management is pivoting toward high-value downstream specialty chemicals like Epoxy resins to reduce commodity exposure.
PNG Jewellers reported strong Q1 FY27 results with revenue growth of 40.7% YoY. The company is focusing on a pan-India 'asset-light' expansion through its LiteStyle sub-brand and FOCO franchise model.
Capri Global delivered strong Q1FY27 performance with Consolidated AUM growing 62% YoY to ₹401.1bn, driven by multi-vertical retail credit and expanding distribution network.
Gallantt Ispat reported Q1 FY27 revenue of ₹1,146 Cr, achieving a 17.8% EBITDA margin. Strategy focuses on full backward integration through captive iron ore mines and renewable power to drive structural profitability.
Q1FY27 revenue grew 21% QoQ to INR 402 Cr, though net losses continued at INR -202 Cr. Strategy focuses on international 5G expansion and AI-ready optical networking solutions.
Beta Drugs Ltd. reports Q1-FY27 revenue of INR 1,255 Mn with 21.83% EBITDA margin. Diversifying beyond core oncology into IVF via Nivian acquisition.
Tata Chemicals delivers resilient growth despite industrial headwinds. Global soda ash pricing remains pressured by Chinese oversupply and Middle East geopolitical shipping costs, while India and agri-segments show margin resilience.
Antelopus Selan reported Q1 FY27 Revenue of ₹132.2 Cr and EBITDA of ₹93.2 Cr (70% margin). PAT surged to ₹53.8 Cr.
Supreme Petrochem reports Q1-FY27 revenue of INR 16,927 Mn with EBITDA margins expanding significantly to 19.53%. The company maintains a debt-free balance sheet with an investable surplus of INR 874 crores.
Tamilnad Mercantile Bank delivered record quarterly results for Q1 FY27, characterized by 23% total business growth and the highest ever net profit in its 105-year history.
Happiest Minds reported Q1 FY27 revenue of ₹62,851 Lakhs, up 14.3% YoY. The company is pivoting towards an AI-native enterprise model with 75%+ GenAI-enabled talent.
Northern Arc delivered robust performance with 41% PAT growth, driven by direct-to-customer expansion crossing a 10,000 crore AUM milestone. The shift toward higher-yielding retail segments is successfully offsetting tight liquidity environments.
Sumitomo Chemical reported resilient Q1FY27 results despite a difficult domestic operating environment. Revenue grew 1% to ₹1,063 cr, while Net Profit surged 20% to ₹215 cr, aided by an insurance claim.
Jubilant Ingrevia reported a strong Q1 FY27 with revenue at a 15-quarter high of INR 1,300 Cr (up 25% YoY). Strategy focuses on the 'Pinnacle' journey, expanding CDMO and Specialty Chemical pipelines.
Q1 FY27 results show flattish Revenue at ₹5,437 Cr and 2% EBITDA growth to ₹3,103 Cr. Management reports massive 1.1 GW capacity additions since April 2026.
LCAL reported its highest-ever quarterly total income and EBITDA in Q1 FY27, driven by improved caustic soda realizations and operational efficiencies.
Aeroflex reported its highest-ever quarterly performance in Q1FY27, driven by a pivot towards high-margin liquid cooling solutions for AI data centers.
BEL presentation highlighting Rs 26,750 Cr turnover (provisional) for FY26 and transition to indigenous technology (84%). Focus on 'Make in India' and aerospace/defence electronics.
Senores Pharmaceuticals delivered strong Q1 FY27 growth, doubling approved ANDAs to 58. Management is pivoting strategy toward profitability in domestic branded generics while scaling US operations via new specialized subsidiaries.
Punjab & Sind Bank reported Q1 FY27 results with Net Profit growth of 23.05% YoY to ₹331 crore. Focus remains on rebalancing toward high-yielding RAM assets and digital transformation.
Welspun Corp achieved its highest ever quarterly EBITDA of ₹756 crore, driven by a global footprint that insulates it from a muted domestic Indian market where fund constraints are impacting projects.
Huhtamaki reported a robust 23.1% revenue growth and significant EBITDA expansion. Performance was driven by a balanced mix of volume, pricing, and high-value product shifts despite raw material volatility.
Usha Martin reported strong Q1 FY27 results with revenue crossing the ₹1,000 crore milestone, driven by record wire rope margins and improved product mix.
Tilaknagar Industries reported robust Q1 FY27 results with Net Revenue crossing INR 1,000 Cr, driven by the successful integration of Imperial Blue and premiumization strategy.
Mold-Tek delivered record Q1 FY27 revenue exceeding 300 crores, driven by high-margin pharma and food segments. EBITDA/kg hit a record 46.7 despite volume headwinds in lubricants.
SMC delivered strong top-line growth across brokerage and insurance, though NBFC operations face consolidation pressures. Management is banking on AI and tech to drive long-term retail scale.
Kfin Technologies reports strong 30% YoY revenue growth driven by international expansion and the Ascent acquisition, though margins face temporary dilution from integration and infrastructure costs.